The innate immune system in cystic fibrosis lung disease

Journal of Clinical Investigation

Volumn 103, Issue 3, 1999, Pages 303-307

  Bals, Robert ^a   Weiner, Daniel J ^a,b   Wilson, James M ^a  

^a WISTAR INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BURKHOLDERIA CEPACIA; CHLORIDE CONDUCTANCE; CYSTIC FIBROSIS; GENE THERAPY; GENETIC DISORDER; HAEMOPHILUS INFLUENZAE TYPE A; HOST RESISTANCE; IMMUNE SYSTEM; LUNG DISEASE; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RNA TRANSLATION; STAPHYLOCOCCUS AUREUS;

EID: 0032906408     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6277     Document Type: Review

References (29)

1. Quinton, P. 1983. Chloride impermeability in cystic fibrosis. Nature, 301:421-422.
2. Rommens, J., et al. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 245:1059-1065.
3. Riordan, J., et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1066-1073.
4. Wilson, J.M. 1995. Gene therapy for cystic fibrosis: challenges and future directions. J. Clin. Invest. 96:2547-2554.
5. Smith, J., Travis, S., Greenberg, E., and Welsh, M. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:229-236.
6. Accurso, F. 1997. Early pulmonary disease in cystic fibrosis. Curr. Opin. Pulm. Med. 3:400-403.
7. Armstrong, D., Grimwood, K., and Carzino, R. 1995. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Brit. Med. J. 310:1571-1577.
8. Bauernfeind, A., Bertele, R., and Harms, K. 1997. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis Infection. 15:270-278.
9. Fearon, D., and Locksley, R. 1996. The instructive role of innate immunity in the acquired immune response. Science. 272:50-54.
10. Wilmott, R., Fiedler, M., and Stark, J.M. 1998. Host defense mechanisms. In Disorders of the respiratory tract in children. V. Chernick and T. Boat, editors. W.B. Saunders. Philadelphia, PA. 238-264.
11. Zasloff, M. 1991. Antibiotic peptides as mediators of innate immunity. Curr. Opin. Immunol. 4:3-7.
12. Ganz, T., and Lehrer, I.R. 1995. Defensins, Pharmacol. Ther. 66:191-205.
13. Diamond, G., et al. 1991. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. USA. 88:3952-3956.
14. Schonwetter, B.S., Stolzenberg, E.D., and Zasloff, M.A. 1995. Epithelial antibiotics induced at sites of inflammation. Science. 267:1645-1648.
15. Bensch, K.W., Raida, M., Magert, H.-J., Schulz-Knappe, P., and Forssmann, W.-G. 1995. hBD-1: a novel b-defensin from human plasma. FEBS Lett. 368:331-335.
16. Harder, J., Bartels, J., Christophers, E., and Schroeder, J.-M. 1997. A peptide antibiotic from human skin. Nature. 387:861.
17. Bals, R., et al. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102:874-880.
18. Goldman, M.J., et al. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell. 88:553-560.
19. Zanetti, M., Gennaro, R., and Romeo, D. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1-5.
20. Gudmundsson, G.H., et al. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:325-332.
21. Bals, R., Wang, X., ZaslofF, M., and Wilson, M.J. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA. 95:9541-9546.
22. Matsui, H., et al. 1999. Evidence for periciliar liquid layer depletion not abnormal ion composition, in the pathogenesis of cystic fibrosis airway disease. Cell. 95:1005-1015.
23. Zabner, J., Smith, J., Karp, P., Widdicombe, J., and Welsh, M. 1998. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol. Cell. 2:397-403.
24. Wine, J.J. 1999. The genesis of cystic fibrosis lung disease. J. Clin. Invest. 103:309-312.
25. Imundo, L., Barasch, J., Prince, A., and Al-Awqati, Q. 1995. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natl. Acad. Sci. USA. 92:3019-3023.
26. Pier, G.B., et al. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 271:64-67.
27. Kelley, T., and Drumm, M. 1998. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. 102:1200-1207.
28. Grasemann, H., Michler, E., Wallot, M., and Ratjen, F. 1997. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr. Pulmonol. 24:173-177.
29. Berger, M., and Konstan, M. 1999. Immunopathogenesis of cystic fibrosis lung disease. In Cystic fibrosis in adults. J. Yankaskas and M. Knowles, editors. Lippincott-Raven Publishers. Philadelphia, PA. 115-143.